Peer Review History
| Original SubmissionDecember 18, 2023 |
|---|
|
PONE-D-23-41698Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: a national study utilizing the National Health Insurance DatabasePLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kentaro Yamada, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating in your Funding Statement: This study was supported by Seoul National University Hospital Research Fund (Grant No. 3020230120), Doosan Yonkang Foundation (Grant No. 800-20210527), and Armed Forces Capital Hospital (Grant No. 2023MDD0075), received by Chi Heon Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please provide an amended statement that declares all the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for submitting this interesting and informative manuscript to PLoS One. I was pleased to receive it as a reviewer. While your manuscript provides valuable insights into an important healthcare topic, there are a few areas that could be refined to further augment the quality and impact of the work. Here are some respectful suggestions that could potentially improve the paper if you choose to implement them: Abstract - The abstract clearly summarizes key aspects, but the conclusion may be strengthened by elaborating on the practice-relevant implications regarding elective surgery policies during pandemics. Introduction - The introduction effectively covers the background of the study. As the discussion notes study limitations regarding generalizability, the introduction could benefit from briefly mentioning upfront that the healthcare infrastructure and pandemic responses likely differ across countries. - Consider further elaborating on the rationale for focusing specifically on degenerative lumbar spinal diseases and surgeries. For example, you could explain if patients with these conditions could be more vulnerable during pandemics versus other spine issues. Methods - The methods are detailed overall. As a suggestion, it could be useful to state if there were any changes to hospital or surgical protocols between the cohorts that could have impacted the results through unmeasured confounders. - Consider providing more details on the propensity score matching process. Which specific variables were included and why? How was the greedy matching algorithm optimized? - Consider explaining the rationale for replacing surgery numbers for holiday weeks with average values. Elaborate on assumptions and implications. Results - When presenting the changes in proportions of surgery types for the diagnoses, consider speculating on potential reasons driving the shifts. This would give readers more context when interpreting the results. Discussion - The discussion provides meaningful interpretation of results and balances the strengths against limitations. To augment the actionability of the conclusions, you could elaborate further on the presumed practice-relevant implications regarding elective surgery decisions during pandemics. - Compare and contrast findings with other COVID-19-era studies on spine surgery trends from different countries to put results into perspective. How and why are they similar or different? - Discuss the degree to which the conclusions can be reasonably extrapolated to healthcare systems with differing infrastructure and pandemic responses compared to the Republic of Korea population. Conclusions - The conclusions concisely summarize the main outcomes. To amplify the impact, you may consider incorporating more specific guidance regarding elective spine surgery policies during future public health emergencies based on your findings. Overall, these suggestions aim to enhance the manuscript's overall quality for clinicians, researchers, and healthcare policy makers. I believe that implementing the above suggestions would make your important work more useful for informing practice under crisis situations. Reviewer #2: Thank you for the opportunity to review the paper by Kim and colleagues regarding a study on the status of spinal surgery during the COVID-19 pandemic in South Korea using real-world data. This is a well-written manuscript and offers valuable societal insights. I read this manuscript with great interest. While I respect the authors' significant effort in extracting detailed information from nationwide population-based data, there are several methodological problems with this study. Major Comments: 1. The utilization of propensity score matching as a method in this study appears inappropriate, given the assumptions associated with this technique. If the intention is to compare pre- and post-population, I would recommend employing regression adjustment incorporating variables pertinent to the outcome of interest. As alternative methods, standardization methods such as Standardized Mortality Ratios (SMR) could be considered. 2. Overall, the paper is redundant in its description. For example, the "patient inclusion" and "variables" sections have room for improvement. 3. (Page 7, line 157-) Although many populations have been excluded, these exclusions may be inappropriate when examining trends in the number of surgeries. 4. (Page 15, line 253-) In applying joinpoint regression, the authors appear to have corrected the data, but I cannot determine if this is appropriate. I'm afraid this data handling may affect the results. Minor comments 1. Many studies have pointed to a decrease in postoperative hospital stay for various surgeries. Consider citing these. 2. (Table 1) The column of CCI is broken; please correct it. Finally, I would like to express my respect for the great effort of the authors in this paper. I hope this paper will be properly revised and published. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Savvas Lampridis Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-41698R1Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: a national study utilizing the National Health Insurance DatabasePLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 21 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kentaro Yamada, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Thank you for your lots of efforts to improve article. Please confirm comments from Reviewer #2, then reply for the 2 questions. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the attention and consideration you have shown to my suggested revisions for your manuscript. It is evident that a significant amount of effort and thought has been directed towards the refining of your work, integrating the feedback provided during the peer review process. The resulting modifications demonstrate a thorough approach and significantly improve the rigor and overall quality of your manuscript. I look forward to witnessing the impact your research will undoubtedly have on the academic community. Reviewer #2: I would like to thank the authors for their considerable effort regarding the revision. My previous comments were appropriately addressed. Therefore, my decision is provisional accept. I recommend that the following minor corrections be considered: 1. It seems that something is wrong in the calculation of the number of cases in cohort A in fig 1. 106217-23661-3094-32-702-321=78407 Please confirm this. 2. Still, in my computer environment, the column of CCI in Table 1 seems to be broken; please confirm this. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Savvas Lampridis Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: a national study utilizing the National Health Insurance Database PONE-D-23-41698R2 Dear Dr. Kim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kentaro Yamada, M.D., Ph.D. Academic Editor PLOS ONE Reviewers' comments: Reviewer #1: Thank you for your continued efforts in addressing Reviewer #2’s concern regarding the calculation of the number of cases in cohort A, as depicted in Figure 1. Regarding Reviewer #2’s second comment, I did not find any issues with Table 1 formatting either. Congratulations on your successful revisions and the forthcoming publication of your work in PLoS One. Reviewer #2: Thanks for the prompt reply. I have ensured that the authors have appropriately addressed the revisions. ********** |
| Formally Accepted |
|
PONE-D-23-41698R2 PLOS ONE Dear Dr. Kim, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kentaro Yamada Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .